[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR9807399A - Composições para o tratamento de ards ou irds contendo 3-(ciclopropilmetóxi)-n-(3,5-dicloro-4-piridinil)-4-(difl uorometoxi)benzamida e tensoativo do pulmão - Google Patents

Composições para o tratamento de ards ou irds contendo 3-(ciclopropilmetóxi)-n-(3,5-dicloro-4-piridinil)-4-(difl uorometoxi)benzamida e tensoativo do pulmão

Info

Publication number
BR9807399A
BR9807399A BR9807399-0A BR9807399A BR9807399A BR 9807399 A BR9807399 A BR 9807399A BR 9807399 A BR9807399 A BR 9807399A BR 9807399 A BR9807399 A BR 9807399A
Authority
BR
Brazil
Prior art keywords
irds
ards
treatment
compositions
cyclopropylmethoxy
Prior art date
Application number
BR9807399-0A
Other languages
English (en)
Other versions
BR9807399B1 (pt
Inventor
Rolf Beume
Dietrich Haefner
Paul-Georg Germann
Klaus Eistetter
Ulrich Kilian
Hermann Amschler
Uwe Krueger
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19705924A external-priority patent/DE19705924A1/de
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of BR9807399A publication Critical patent/BR9807399A/pt
Publication of BR9807399B1 publication Critical patent/BR9807399B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Patente de Invenção: <B>"COMPOSIçõES PARA O TRATAMENTO DE ARDS OU IRDS CONTENDO 3-(CICLOPROPILMETóXI)-N-(3,5-DICLORO-4-PIRIDINIL)-4-(DIFL UOROMETOXI)BENZAMIDA E TENSOATIVO DO PULMãO"<D>. Novas composições para o tratamento de IRDS e ARDS são indicadas, que contêm N-(3,5-dicloropirid-4-il)-3-ciclopropilmetóxi-4-difluoro-metoxibenzamid a e/ou seus sais farmacologicamente toleráveis e tensoativo do pulmão.
BRPI9807399-0A 1997-02-17 1998-02-14 composição para o tratamento de sìndrome da angústia respiratória infantil (irds) ou sìndrome da angústia respiratória aguda (ards) compreendendo 3-(ciclopropilmetóxi)-n-(3,5-dicloro-4-piridinil)-4-(difl uorometóxi) benzamida e tensoativo do pulmão, e seu uso. BR9807399B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19705924A DE19705924A1 (de) 1997-02-17 1997-02-17 Neue Zusammensetzungen
EP97102639 1997-02-19
PCT/EP1998/000847 WO1998035683A1 (en) 1997-02-17 1998-02-14 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant

Publications (2)

Publication Number Publication Date
BR9807399A true BR9807399A (pt) 2000-03-14
BR9807399B1 BR9807399B1 (pt) 2011-04-19

Family

ID=26033977

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9807399-0A BR9807399B1 (pt) 1997-02-17 1998-02-14 composição para o tratamento de sìndrome da angústia respiratória infantil (irds) ou sìndrome da angústia respiratória aguda (ards) compreendendo 3-(ciclopropilmetóxi)-n-(3,5-dicloro-4-piridinil)-4-(difl uorometóxi) benzamida e tensoativo do pulmão, e seu uso.

Country Status (26)

Country Link
US (2) US6436970B1 (pt)
EP (1) EP0977577B1 (pt)
JP (1) JP4763104B2 (pt)
KR (1) KR100640025B1 (pt)
CN (1) CN1123345C (pt)
AT (1) ATE336254T1 (pt)
AU (1) AU734122B2 (pt)
BR (1) BR9807399B1 (pt)
CA (1) CA2276429C (pt)
CZ (1) CZ293871B6 (pt)
DE (1) DE69835594T2 (pt)
DK (1) DK0977577T3 (pt)
EA (1) EA001758B1 (pt)
EE (1) EE04094B1 (pt)
ES (1) ES2271990T3 (pt)
HK (1) HK1026145A1 (pt)
HU (1) HU227520B1 (pt)
IL (1) IL130658A (pt)
NO (1) NO323594B1 (pt)
NZ (1) NZ336569A (pt)
PL (1) PL190775B1 (pt)
PT (1) PT977577E (pt)
SI (1) SI0977577T1 (pt)
TR (1) TR199901772T2 (pt)
UA (1) UA50808C2 (pt)
WO (1) WO1998035683A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227520B1 (hu) * 1997-02-17 2011-07-28 Nycomed Gmbh ARDS és IRDS kezelésére szolgáló, 3-(ciklopropil-metoxi)-N-(3,5-diklór-4-piridinil)-4-(difluor-metoxi)-benzamidot és tüdõfelületaktív anyagot tartalmazó kompozíció
WO2001019392A1 (en) * 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
AU2001261962B2 (en) 2000-05-25 2005-04-21 Merck Frosst Canada Ltd Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
DE60205899T2 (de) 2001-05-24 2006-06-29 Merck Frosst Canada & Co, Kirkland 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
WO2003053455A1 (en) * 2001-12-12 2003-07-03 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
US20030170223A1 (en) * 2002-02-01 2003-09-11 Board Of Trustees Of Michigan State University Pulmonary vasodilator surfactant compositions and method of use
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
ATE399544T1 (de) * 2002-11-27 2008-07-15 Nycomed Gmbh Synergistische zusammensetzung enthaltend roflumilast und (r,r)-formoterol
ATE399543T1 (de) * 2002-11-27 2008-07-15 Nycomed Gmbh Neue synergistische zusammensetzung enthaltend roflumilast und formoterol
MXPA04008070A (es) 2003-03-10 2004-11-26 Altana Pharma Ag Novedoso proceso para la preparacion de roflumilasto.
JP2006527737A (ja) * 2003-06-16 2006-12-07 アルタナ　ファルマ　アクチエンゲゼルシャフト 肺サーファクタントとｐｄｅ５阻害剤とを含有する肺疾病の治療用の組成物
AU2005268755B2 (en) 2004-08-06 2011-04-07 Takeda Gmbh Composition comprising a pulmonary surfactant and a TNF-derived peptide
EP1861074B1 (en) * 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
WO2008076265A1 (en) * 2006-12-13 2008-06-26 Gilead Sciences, Inc. MONOPHOSPHATES AS MUTUAL PRODRUGS OF ANTI-INFLAMMATORY SIGNAL TRANSDUCTION MODULATORS (AISTM'S) AND β-AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION
WO2009055788A1 (en) * 2007-10-26 2009-04-30 Aeris Therapeutics, Inc. Pneumoreductive therapy and compositions useful therein
ES2909752T3 (es) * 2013-08-01 2022-05-10 Swedish Stromabio Ab MSC en el tratamiento de enfermedades pulmonares inflamatorias
CN104800214A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入气雾剂复方及制备方法
RU2728821C1 (ru) * 2020-05-13 2020-07-31 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства" (ФГБУН НЦБМТ ФМБА России) Способ лечения острого респираторного дистресс-синдрома даларгином и легочным сурфактантом

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223040A (en) * 1974-11-26 1980-09-16 Carroll John M Lauric acid for the prevention and treatment of mycobacterial diseases
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤
GR82072B (pt) * 1983-05-11 1984-12-13 Byk Gulden Lomberg Chem Fab
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
CA2165192C (en) * 1993-07-02 2001-04-24 Hermann Amschler Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
US5856196A (en) * 1993-10-25 1999-01-05 Beth Israel Hospital Processes for quantitating phosphoglycerides in a lipid mixture and diagnostic uses therefor
GB9401460D0 (en) 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
DE4434629C1 (de) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
HU227520B1 (hu) * 1997-02-17 2011-07-28 Nycomed Gmbh ARDS és IRDS kezelésére szolgáló, 3-(ciklopropil-metoxi)-N-(3,5-diklór-4-piridinil)-4-(difluor-metoxi)-benzamidot és tüdõfelületaktív anyagot tartalmazó kompozíció
US6180142B1 (en) * 1998-08-21 2001-01-30 The Regents Of The University Of California Reduction of surfactant inactivation in pulmonary surfactant therapy
JP2003503830A (ja) * 1999-06-29 2003-01-28 エル−テック コーポレイション 化学的膜洗浄及び乾燥

Also Published As

Publication number Publication date
PL335134A1 (en) 2000-04-10
EE9900279A (et) 2000-02-15
DE69835594D1 (de) 2006-09-28
KR100640025B1 (ko) 2006-10-31
AU6497398A (en) 1998-09-08
EE04094B1 (et) 2003-08-15
SI0977577T1 (sl) 2007-02-28
HUP0001043A3 (en) 2002-12-28
TR199901772T2 (pt) 1999-09-21
KR20000071112A (ko) 2000-11-25
WO1998035683A1 (en) 1998-08-20
NZ336569A (en) 2001-04-27
DK0977577T3 (da) 2006-12-18
EP0977577A1 (en) 2000-02-09
IL130658A0 (en) 2000-06-01
US6998410B2 (en) 2006-02-14
CZ293871B6 (cs) 2004-08-18
PL190775B1 (pl) 2006-01-31
BR9807399B1 (pt) 2011-04-19
CA2276429C (en) 2007-06-19
NO323594B1 (no) 2007-06-11
CN1248169A (zh) 2000-03-22
EA199900645A1 (ru) 2000-04-24
CN1123345C (zh) 2003-10-08
EP0977577B1 (en) 2006-08-16
HK1026145A1 (en) 2000-12-08
CA2276429A1 (en) 1998-08-20
US6436970B1 (en) 2002-08-20
EA001758B1 (ru) 2001-08-27
NO993875D0 (no) 1999-08-11
HUP0001043A2 (hu) 2000-09-28
PT977577E (pt) 2007-02-28
CZ291499A3 (cs) 2000-02-16
ATE336254T1 (de) 2006-09-15
NO993875L (no) 1999-08-11
IL130658A (en) 2004-07-25
AU734122B2 (en) 2001-06-07
HU227520B1 (hu) 2011-07-28
ES2271990T3 (es) 2007-04-16
UA50808C2 (uk) 2002-11-15
DE69835594T2 (de) 2007-08-16
JP4763104B2 (ja) 2011-08-31
JP2001512452A (ja) 2001-08-21
US20020132835A1 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
BR9807399A (pt) Composições para o tratamento de ards ou irds contendo 3-(ciclopropilmetóxi)-n-(3,5-dicloro-4-piridinil)-4-(difl uorometoxi)benzamida e tensoativo do pulmão
BR0208105A (pt) Inibidores de metaloproteinase
BR0014293A (pt) Uso de retigabina para o tratamento de dor neuropática
BR0207873A (pt) Compostos de amÈnio quaternário contendo misturas preservativas
BR9910583A (pt) Aminotetralinas n-substituìdas como ligantes para o receptor de neuropeptìdeo y y5 úteis no tratamento de obesidade e outros distúrbios
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
DK1259485T3 (da) Benzamider og beslægtede inhibitorer for faktor Xa
ATE356130T1 (de) Inhibitoren von cruzipain und anderen cysteinproteasen
DK0712311T3 (da) Antiglucocorticoidsteroider til behandling af angstlidelser
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
DK0810991T3 (da) 1-Aryl-2-acylamino-ethan-forbindelser og deres anvendelse som neurokinin- især neurokinin-1-antagonister
BR0314844A (pt) Novo composto
SE0101327D0 (sv) New crystalline forms
BR0314843A (pt) Novo composto
DK0736020T3 (da) 6-(2-imidazolinylamino)quinolinforbindelser, der er egnede som alfa-2-adrenoceptoragonister
BR0113650A (pt) N-(3,5-dicloro-2-metoxifenil)-4-metóxi-3-piperazina-1-il a-benzenossulfonamida
PT1161239E (pt) 3-ciclopropilmetoxi-4-difluorometoxi-n-(3,5-dicloropirid-4-il)-benzamida para o tratamento da esclerose multipla
NO20002408D0 (no) 5-HT1F antagonister
BR0007183A (pt) Isonipectoamidas para o tratamento de distúrbios mediados por integrina
NO975084D0 (no) Bakteriostatisk preparat og dets anvendelse i metallbearbeidingsfluider
BR9809666A (pt) Aplicação de 1-ar(alqu)il-imidazolin-2-onas para o tratamento de estados de ansiedade e tensão
BR9714189A (pt) N-(piridinilamino) isoindolinas e compostos relacionados
ATE214543T1 (de) Aldehydfreie desinfektionsmittel für flächen und instrumente
BR9911574A (pt) Ciclooctadepsipeptìdeos substituìdos
RS52014B (sr) Nova so benzoilgvanidina

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADA DE INT.CL.8: A61K 31/44, A61K 31/66, A61K 38/17, A61P 11/00

Ipc: A61K 31/44 (2007.01), A61K 31/66 (2007.01), A61K 3

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: NYCOMED GMBH (DE)

Free format text: ALTERADO DE: ALTANA PHARMA AG

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/04/2011, OBSERVADAS AS CONDICOES LEGAIS.

B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B25A Requested transfer of rights approved

Owner name: NYCOMED ASSET MANAGEMENT GMBH (DE)

B25A Requested transfer of rights approved

Owner name: NYCOMED GERMANY HOLDING GMBH (DE)

B25D Requested change of name of applicant approved

Owner name: TAKEDA GMBH (DE)

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 20A ANUIDADE.

B25A Requested transfer of rights approved

Owner name: ASTRAZENECA AB (SE)

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)